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Abstract
Patients with endometriosis and adenomyosis naturally improve after menopause. 
Therefore, some patients only need to relieve symptoms, especially those near 
menopause, and they prefer to be treated by conservative methods. We summarized 
several minimally invasive interventional methods: uterine artery intervention 
(Uterine artery embolization, UAE), nerve intervention (upper and lower abdomi-
nal plexus block, SHPB), ultrasound intervention (puncture sclerotherapy; high 
intensity focused ultrasound treatment).
Keywords: superior hypogastric plexus block, uterine artery embolization, 
ultrasound interventional
1. Introduction
Adenomyosis and endometriosis are common gynecological diseases. Most of 
the patients are primipara aged 35–50 years old. About half of the patients have 
hysteromyoma at the same time. Clinical manifestations are dysmenorrhea, men-
strual disorders, and enlargement of the uterine body. Secondary dysmenorrhea 
and Menorrhagia are the most typical symptoms of this disease [1].
The main symptom of endometriosis is progressive secondary dysmenorrhea 
which severely affects patient’s quality of life. Menorrhagia caused by adenomyosis 
may lead to severe anemia in some patients. The treatment is often personalized 
and optimized according to disease severity and patient age. At present, there are 
several non-surgical conservative treatments for secondary dysmenorrhea and 
menorrhagia.
2. Minimally invasive interventional therapies
2.1 Uterine artery embolization (UAE)
UAE is the treatment of symptomatic uterine fibroids by embolizing the vascular 
network of the lesion after reaching the uterine artery through the intervention, 
which blocks the blood supply of the lesion [2]. It was first reported in 1995 by 
Ravina et al. This technique has the characteristics of uterus preservation, easy 
operation, rapid postoperative recovery, and less postoperative complications and 
has become one of the effective minimally invasive alternatives in the treatment 
of symptomatic uterine adenomyosis. The American College of Obstetricians and 
Gynecologists (ACOG) has recommended UAE as a safe and effective treatment 
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option for patients with uterine fibroids who wish to preserve the uterus (level A 
evidence) [3]. Therefore, UAE has been widely used in the treatment of uterine 
leiomyoma, and then UAE has achieved significant effect in the treatment of pain 
and anemia symptoms of adenomyosis, but there is controversy in the use of adeno-
myosis, which may recur after a period of time due to symptoms [4]. In recent years, 
more and more literatures show that UAE is effective in the treatment of adenomyo-
sis, especially in the short term [5–7]. UAE treatment alleviated the symptoms of 
adenomyosis and made most adenomyosis patients retain the uterus [8].
2.1.1 Rationale for UAE in uterine adenomyosis
Adenomyosis is a diffuse or local proliferation of surrounding smooth muscle and 
fibrous connective tissue caused by glandular and stromal invasion of the basal layer 
of the endometrium, and the ectopic endometrium is in the proliferative phase due 
to its origin from the basal layer of the endometrium. The above lesions have a rela-
tively rich network of new blood vessels and poor tolerance to ischemia and hypoxia, 
but the normal uterine tissue has a rich vascular traffic network, and the normal 
uterus has a strong tolerance to ischemia and hypoxia. Embolization of the vascular 
network of the lesion through the uterine artery blocks the blood supply of the lesion 
(after), resulting in ischemic necrosis of the lesion, followed by dissolution and 
absorption, and finally the lesion shrinks or even disappears, while the reduction of 
the lesion reduces the uterine volume and uterine cavity area, which can effectively 
reduce the menstrual volume, so as to achieve the purpose of relieving symptoms.
2.1.2 Indications and contraindications of UAE
2.1.2.1 Indications
(1) Patients are willing to undergo UAE treatment and understand the relevant 
possible complications. (2) Symptomatic adenomyosis without fertility require-
ments, including dysmenorrhea and heavy menstrual bleeding. (3) Patients with 
uterine adenomyosis who fail non-surgical treatment or refuse surgery or have a 
history of multiple surgeries and are difficult to treat by reoperation. (4) Patients 
with pelvic endometriosis (including ovarian endometrioma) at the same time, 
need to inform UAE is ineffective for the above disease, in patients with full under-
standing and requirements, the option of UAE treatment of adenomyosis combined 
with laparoscopic treatment of pelvic endometriosis (including ovarian endome-
trioma). (5) Patients with symptomatic uterine adenomyosis who have fertility 
requirements should use UAE with caution. In terms of indications, we have repeat-
edly stressed that UAE should be carefully selected for patients with adenomyosis 
who have fertility requirements. The reason is that the medium- and long-term 
effects of UAE on endometrial microcirculation or intrauterine environment is still 
uncertain. UAE needs to be performed under X-ray. The skill level of the operator 
and the vascular condition of the patient are linear, which will affect the amount of 
radiation received by the patient, and the effect of radiation on the fertility rate is 
also uncertain. This kind of research is rare, because it involves ethical review and 
cannot be passed.
2.1.2.2 Contraindications
(1) Pregnant women; (2) combined with genitourinary system infection; (3) 
known or suspected gynecological malignant tumors coexist; (4) general contra-
indications of interventional embolization therapy, such as contrast agent allergy, 
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puncture site skin infection, renal insufficiency, or severe immunosuppression of 
the body; and (5) patients with uterine fibroids or adenomyosis whose lesions are 
mainly supplied by the ovarian artery [9].
2.1.3 Preoperative evaluation of UAE
2.1.3.1 History and evaluation
These include detailed gynecological history, such as menstrual history, previ-
ous pregnancy, fertility plan, gynecological disease, and previous pelvic surgery, 
medical history to identify various comorbidities, and previous use of anticoagu-
lants. Adequate informed consent is required, and informed consent for surgical 
procedures is signed to understand the advantages and disadvantages of treatment, 
expected effects, and potential complications.
2.1.3.2 Evaluation of dysmenorrhea
A comprehensive assessment of the degree of recent and long-term dysmenor-
rhea in patients with adenomyosis was performed using the visual analog scale 
(VAS) for pain and the chronic pain rating scale. The clinical evaluation standard 
of dysmenorrhea symptoms: the degree of dysmenorrhea was evaluated by chronic 
pain rating scale before and after operation. We used VAS to evaluate the degree of 
dysmenorrhea at each follow-up time point, and VAS weighted calculation method 
to evaluate the efficacy of UAE in the treatment of dysmenorrhea in adenomyosis. 
Effective: the postoperative dysmenorrhea disappeared or the postoperative dys-
menorrhea symptoms existed, but the score of chronic pain rating scale decreased 
by two or more levels, (1) cured: (preoperative VAS score − postoperative VAS 
score)/preoperative VAS score × 100% ≥ 75%; (2) effective: (preoperative VAS 
score − postoperative VAS score)/preoperative VAS score × 100% ≥ 50% and < 75%; 
(3) effective: (preoperative VAS score − postoperative VAS score)/preoperative VAS 
score × 100% ≥ 25% and < 50%. No effect: the symptoms of dysmenorrhea after 
operation exist, the score of chronic pain rating scale is only reduced by one grade, 
or the dysmenorrhea is not relieved or even continues to increase, or (preoperative 
VAS score − postoperative VAS score)/preoperative VAS score × 100% < 25%.
2.1.3.3 Clinical evaluation criteria for menstrual volume
Menorrhagia was defined as menstrual flow >80 ml per menstrual cycle (more 
than 20 sanitary napkins were used); oligomenorrhea was defined as menstrual 
flow <5 ml per menstrual cycle (less than 1 sanitary napkin was used). Clinical 
evaluation standard of menstrual volume: subjective symptoms of patients. 
Significant effect: after UAE treatment, menstrual volume decreased significantly. 
Effective: after UAE treatment, menstrual volume decreased. No effect: after UAE 
treatment, the menstrual volume was not significantly reduced.
2.1.3.4 Examination before treatment
In addition to routine preoperative examinations, sex hormone levels were 
measured to assess ovarian function. Because the influence of uterine artery 
embolization on ovarian function is uncertain. Blood CA125 levels were mea-
sured for follow-up, CA125 was used as a follow-up index because we found that 
most patients with adenomyosis have different degrees of increase in this index. 
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The reason is that the serum CA125 antigen of patients with this disease is secreted 
by ectopic endometrium between muscles, and CA125 molecules on the surface of 
endometrial cells are released into the blood circulation, which increases the con-
centration of CA125 antigen in the blood. Several studies [10] also show that serum 
CA125 assay is of great assistance to the diagnosis of uterine adenomyosis. Blood 
CA125 levels were measured for follow-up. Venous color Doppler ultrasonography 
of both lower limbs is particularly important to assess the presence or absence of 
preoperative thrombosis.
2.1.3.5 Imaging evaluation
MRI examination, ultrasonography, CT, and other assessments, which perform 
the planning of the surgical approach and reduce the blindness of the procedure, 
can improve the success rate of surgery. By contrast, most studies recommend MRI 
as the main preoperative evaluation method.
2.1.4 Operating process of UAE
The patient was placed in supine position. Routine disinfection and draping 
were performed. After local anesthesia, the right femoral artery was punctured 
by Seldinger method. The catheter sheath was placed. A 5F Cobra catheter was 
inserted into the opening of bilateral uterine arteries for DSA. The dosage of 
contrast medium on each side was 6 ml and the flow rate was 2 ml/s. The uterus 
was significantly enlarged, the uterine artery was significantly thickened and tor-
tuous, and the staining in the uterus was thickened. If there was uterine fibroids, 
the angiography showed the presence of “holding ball” abnormal vascular mass. 
The 3F microcatheter was used to superselect to the distal end of the main uterine 
artery, avoiding the ovarian artery. The uterine artery was embolized with embolic 
agent. The DSA was reexamined. The abnormal staining of the uterus disappeared, 
and the main uterine artery was retained. The operation could be ended.
2.1.4.1 Selection of embolic agent
There are many embolization agents available for UAE. Generally, particle emboliza-
tion agents are selected. Generally, they can be divided into absorbable and non-absorb-
able. Absorbable embolization agents are represented by gelatin sponge particles, and 
non-absorbable embolization agents are represented by polyvinyl alcohol embolization 
microspheres (embosphere). However, the commonly used embolic agents of other 
organs, such as steel ring, absolute ethanol, and super-liquid iodized oil, are not recom-
mended for use in UAE. For the selection of embolic agent particle size, “sandwich 
embolization” should be used for embolization of uterine adenomyosis due to the small 
inner vascular network. First, particles with a diameter of 100–300 μm are selected for 
embolization of the inner vascular network, particles with a diameter of 300–500 μm 
are used for embolization of the outer vascular network, and finally particles with a 
diameter of 500–700 μm are used for trunk embolization [11]. The effect of arterial 
embolization is inversely proportional to the embolic agent particle size.
2.1.4.2 Degree of embolism
Embolization is divided into two types: complete embolization and incomplete 
embolization. Patients with uterine adenomyosis require complete embolization of the 
inner vascular network of the uterus, and in DSA, imaging findings show complete 
disappearance of focal staining, visualization of the main trunk of the uterine artery, 
retention of contrast agent, and no clearance of contrast agent in five cardiac cycles.
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2.1.5 Postoperative management of UAE
For hemostasis by compression at the puncture site, the lower limbs were immobi-
lized for 6 h. If a vascular sealer was used, the immobilization time could be short-
ened. After operation, it is necessary to observe the skin color and skin temperature of 
lower limbs, ask the dorsalis pedis artery pulse and mark it, and make regular obser-
vation to prevent thrombosis. Antibiotics were not routinely applied postoperatively.
2.1.6 Complications of UAE
2.1.6.1 Intraoperative complications
1. Local bleeding or hematoma: bleeding or hematoma at the puncture site is a 
more common complication, and severe cases can cause large pelvic retro-
peritoneal hematoma. Hemostasis by compression was given for symptomatic 
treatment.
2. Arterial spasm: repeated stimulation of blood vessels or long operation time 
during surgery may cause arterial spasm, cause limb numbness and pain, 
affect intraoperative operation, and in severe cases, lead to limb ischemic 
necrosis. Analgesic drugs can be used to relieve pain and intraoperative 
application of 2% lidocaine 5 ml local intra-arterial injection.
3. Arterial puncture injury: although arterial puncture injury caused by improper 
operation or traumatic operation is rare during the operation, because the pel-
vic artery is located in the retroperitoneum, once it occurs, it will be difficult 
to compress and stop bleeding, which can form retroperitoneal hematoma. 
Failure to timely detect it will threaten the patient’s life and require emergency 
laparotomy for hemostasis. Therefore, intraoperative manipulation should be 
gentle, and the direction of the vessel should be identified when resistance is 
encountered, homeopathic.
2.1.6.2 Postoperative complications
1. Pain: almost all patients experience pain after surgery. At present, it is believed 
that pain is associated with ischemia of the lesion and uterus after UAE. The 
degree of pain varies from mild to severe colic. Analgesic methods depend on 
the severity of pain and preemptive non-steroidal anti-inflammatory drugs, 
patient-controlled analgesia, oral or parenteral administration of opioids using 
analgesic pumps are optional. The duration of pain varies and is generally 
gradually relieved 2 to 5 days after surgery. If the pain is more than 1 week and 
more severe, we should be alert to the possibility of serious complications such 
as secondary infection and thrombosis.
2. Post-embolization syndrome: post-embolization syndrome is characterized 
by pelvic pain, nausea, vomiting, fever, fatigue, myalgia, discomfort, and 
leukocytosis. Most of them occurred within 24 h after surgery and gradually 
improved within 7 days. It is a common postoperative complication. Postopera-
tive fever is generally no higher than 38°C, which is postoperative absorption 
fever, and antibiotic treatment is usually not required.




4. Misthrombosis of blood vessels: because the anterior trunk of the internal iliac 
artery not only gives off the uterine artery but also the bladder artery, vaginal 
artery, and internal pudendal artery, when the iliac artery and the above arter-
ies are misembolized, complications such as labia majora and minora necrosis 
and local bladder necrosis may occur.
5. Infection: the operation of UAE is a type I incision, and incision infection is 
rare, mainly necrosis of the lesion after embolization, forming aseptic inflam-
mation. After uterine artery interventional therapy, uterine ischemic focus 
atrophied and vaginal secretion increased. At that time, the uterus is prone to 
secondary bacterial infection, and in the worst case, hysterectomy is needed to 
control sepsis. Intrauterine adhesions can be seen in long-term complications.
6. Allergic reactions or rashes: anti-allergic treatment may be given.
7. Bloody vaginal discharge: usually within 2 weeks, a very small number may 
also last for months.
8. Oligomenorrhea: after surgery, some patients have partial endometrial necro-
sis due to uterine artery vascular network embolization, and menstrual volume 
may be significantly reduced, but hormone examination shows no significant 
abnormality. If there is no fertility requirement, this part of patients can be 
observed without treatment.
9. Amenorrhea: it is a long-term complication of UAE and is divided into 
ovarian amenorrhea and uterine amenorrhea. Ovarian amenorrhea is 
mainly caused by ovarian ischemia and necrosis due to blocking of blood 
flow in the arteries supplying the ovary, such as the ovarian branch of the 
uterine artery or the ovarian artery and amenorrhea due to ovarian failure, 
requiring long-term oral administration of hormone drugs to maintain the 
level of hormones in the body. Uterine amenorrhea is caused by endome-
trial ischemic necrosis and impaired endometrial growth, which does not 
affect hormone secretion and can be observed, but the patient is unable to 
have children.
10. Others: other serious complications are rare. The incidence of venous throm-
boembolic complications is approximately 0.4%. Rare complications such 
as fatal sepsis, femoral nerve injury, iliac artery embolism, uterine ischemic 
infarction, labia majora and minora necrosis, local bladder necrosis, vesico-
uterine fistula, uterine wall injury, and necrosis of both toes or heels due to 
extravasation of embolic agents associated with the UAE procedure also occur. 
Readmission was required in 2.4 to 3.5% of patients and unplanned surgery 
in 1.0 to 2.5% of patients. However, overall mortality from UAE was not 
 increased compared with hysterectomy [9].
2.1.7 Follow-up time and efficacy evaluation after UAE treatment
2.1.7.1 Follow-up time
After UAE treatment, reexamination assessment is required at 1, 3, and 
6 months, and once a year thereafter. The contents of follow-up included change of 
lesion size, menstruation, sex hormone level, change of dysmenorrhea degree, and 
CA125 level in patients with adenomyosis.
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2.1.7.2 Clinical efficacy evaluation
A large number of clinical trial data [11, 12] showed that 97–100% of patients could 
tolerate and complete the operation, 77–97.4% of patients had improvement of dysmen-
orrhea symptoms, and amenorrhea happens occasionally. About 20% of patients need 
operation or second UAE because of unsatisfactory effect or recurrence of symptoms.
2.2 Nerve intervention: The superior hypogastric plexus block
2.2.1 Rationale for SHPB in uterine adenomyosis
The superior hypogastric plexus consists of the lumbar splanchnic nerves (from 
the L3–L4 sympathetic ganglia) and the abdominal aortic plexus, which distributes 
its fibers to the anterior sacral promontory of the L5 vertebral body below the iliac 
bifurcation of the abdominal aorta [13]. The superior and inferior ventral nerve 
block was derived from the sacral neurotomy 20 years ago. Under the guidance of 
CT, the puncture needle was placed around the superior and inferior ventral nerve 
in front of the cone, and anhydrous alcohol or other nerve blockers were used to 
block the nerve so that local pain cannot be transmitted back to the brain through 
the nerve, to achieve the purpose of analgesia [14].
2.2.2 Indications and contraindications of SHPB
2.2.2.1 Indications
(i) An ultrasonogram indicated uterine adenomyosis, with a slight increase of 
the cancer antigen (CA)-125 or (ii) there was a history of relevant endometriosis 
operation along with the absence of surgical indications for immediate reopera-
tion. Patients who satisfied either criterion were then included if they met all the 
following additional criteria: (iii) periodic hypogastric pain during menstruation, 
with a visual analog scale (VAS) score >6 (severe); (iv) age >40 years; (v) absence 
of menorrhagia and significant pelvic mass; and (vi) absence of dysmenorrhea due 
to intrauterine devices. Among the patients who satisfied these criteria, we enrolled 
those who provided written informed consent to undergo an operation.
2.2.2.2 Contraindications
The contraindications were as follows: (i) Nulliparous; (ii) Complications due 
to other pelvic diseases; (iii) Acute appendicitis, acute pelvic inflammatory disease; 
(iv) Deep endometriosis; (v) Allergic to alcohol or iohexol.
2.2.3 Operating process of SHPB
The patient was asked to lie on the CT table with a suitable pillow under the 
abdomen. After confirming the absence of any contraindications to a neural block, an 
intravenous infusion channel was opened. CT scans are used to confirm the location 
of the L5 and S1 intervertebral spaces, which are the target regions for puncture. Then, 
the coronal CT scan is obtained by taking the puncture space as the midline, including  
the upper, lower and central sections with a thickness of 3 mm. Select the best punc-
ture section from CT images and plan the puncture path. The anterolateral margin 
of the lumbar 5 was the left margin and the anterior margin of the psoas major was 
the right margin. After planning the puncture route and bilateral puncture points, the 
angle and depth of puncture points were measured with CT ruler. According to the 
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measurement results, place the puncture needle to the target (Figure 1). A solution of 
2% lidocaine containing iohexol (a contrast agent) was injected, and its distribution 
was observed on a CT rescan. An injection site is determined as appropriate if: (i) the 
lidocaine-iohexol solution is distributed along the anteromedial margin of the psoas 
major muscle and the anterior vertebral body (Figure 2) and (ii) a loss of sensation 
bilaterally in the lower limbs without dyskinesia is observed after 15 min. With the 
injection site confirmed, a contrast medium of dehydrated alcohol solution (4 mL) 
containing 3% iohexol (0.5 mL) is injected bilaterally to achieve a neurolytic block of 
the superior hypogastric plexus. This is followed by repeated CT, and three-dimensional 
Figure 2. 
Upper and lower abdominal nerve block by puncture injection.
Figure 1. 
The upper and lower abdominal nerve block was performed by puncture and injection (Three-dimensional 
reconstruction by CT).
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reconstruction to observe the distribution of the dehydrated rate, blood pressure. At 
the same time blood oxygen saturation level is recorded. Any complications are also 
recorded.
2.2.4 Follow-up time and efficacy evaluation after SHPB treatment
At present, there is no reliable follow-up data of big data, but according to the 
existing experience, the effective rate is 70%, the duration is 1–3 years, and there is 
no serious complications related to nerve block. Sacral neurotomy as the predeces-
sor of nerve block treatment appeared 20 years ago, but the technology of nerve 
block by drugs is still very young. The improvement methods can be as follows: to 
study the characteristics and efficacy of different nerve blockers, to improve the 
puncture approach and the position of the blocking point, etc. [15]. SHPB is a new 
way of treatment. There are no data about future fertility. The upper and lower 
abdominal nerves are the proximal part of sacral nerves. The same reason is that 
there are few data at present, which cannot explain the effect of nerve block on 
fertility, sexual function and urination function.
2.3 Ultrasound interventional therapy for endometriosis
2.3.1 Pelvic endometriosis
Ultrasound-guided puncture sclerotherapy [16], sclerosing agent selection includes 
anhydrous ethanol, lauryl alcohol, etc. Anhydrous ethanol is less used due to easy to 
cause low fever, sharp pain, allergies and drunk-like reactions and other adverse reac-
tions poly(lauryl alcohol), the scientific name of polyoxyethylene lauryl alcohol ether, 
is called polydocanol in Europe. After the injection into the cyst, the protein of the cell 
will be precipitated quickly, the double molecular layer of the cell wall will be destroyed, 
the epithelial cells of the cyst wall will be necrotic, the secretion of the fluid of the cell 
will be inhibited, and the aseptic inflammation will be produced to make the fibrosis of 
the cyst wall, so as to achieve the purpose of curing the cyst. The drug is widely used. 
Before the operation, the number and nature of the cyst were confirmed. Under the 
guidance of real-time ultrasound positioning, the puncture needle entered the center 
of the cyst, extracted the fluid from the cyst, rinsed the wall of the cyst repeatedly with 
normal saline, and finally injected with poly(lauryl alcohol) for retention, with a total 
volume of <50 ml. The results showed that the total effective rate of ultrasound inter-
vention was 93.75%, which had little effect on ovarian reserve function.
2.3.2 Adenomyosis
High intensity (frequency < 1 MHz) focused ultrasound can be used to treat 
adenomyosis [17]. High intensity focused ultrasound (HIFU) can promote low-
frequency and high-energy ultrasound to reach the target tissue through the body 
surface fat. It makes use of the cavitation, mechanical and thermal effects of ultra-
sound to induce irreversible damage and degeneration of adenomyosis cells. After 
the operation, the volume of the lesion was reduced, the symptoms of the patients 
were relieved, and the treatment process was safe.
3. Conclusions
The symptoms of endometriosis and adenomyosis are different from each other; so, 
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